Leadership & Pay ·
Exagen Inc. held its 2026 annual meeting of stockholders on June 9, 2026, where stockholders' final voting results are…
XGNExagen Inc.
Exagen Inc. held its 2026 annual meeting of stockholders on June 9, 2026, where stockholders' final voting results are final. Tina S. Nova, Ph.D. and Scott Kahn, Ph.D. were elected as Class I directors for a three-year term. The stockholders' advisory vote on executive compensation was also conducted. Exagen Inc. operates in the biotechnology/healthcare/life sciences industry and develops products for immune system regulation.